Analysis of ALS patient-derived and engineered cells revealed that mutant UBQLN2 increases mRNA and protein of MAP1B which is mediated by dephosphorylation of FUS within its RNA-binding domain. This evidence concerns the gene UBQLN2 and amyotrophic lateral sclerosis.